Krylova Olga, Marchenko Sevara, Ermolaeva Alexandra, Shustikova Natalia, Dyakonova Kristina
Olga Krylova Associate Professor, Department of Pharmacy, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
Sevara Marchenko Associate Professor, Department of Organization and Management in the Field of Medicines Circulation, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
Pak J Med Sci. 2024 Sep;40(8):1853-1859. doi: 10.12669/pjms.40.8.9855.
Goal of the study was to systematically review competitive advantages of medical devices for glucose monitoring in diabetic patients.
The review is done systematically according to SALSA criteria and PRISMA guidelines. The search for eligible articles was held from February 16 2023 to March 1 2023 in Russian and English languages. The results were synthesized narratively, tabularly, and visually. The search was conducted in the following databases of scientific literature: PubMed, IEEE Xplore, Google Scholar, CyberLeninka, and eLibrary.
Twenty-two out of fifty-two manuscripts met the inclusion criteria. The most promising and advantageous characteristics of the evaluated devices, as identified by researchers, include the following: the capability for noninvasive examination; features that facilitate use by patients with fine motor, hearing, and visual impairments; add-ons and software designed to improve patient compliance, including in pediatric populations; and device attributes that enhance the speed and accuracy of analysis while being free of iatrogenic effects.
With increasing prevalence of diabetes, glycemic control is crucial for preventing complications. The market offers numerous glucose monitoring devices (GMDs) with varying features, making selection challenging. Our study systematically categorized the strengths of each GMD model for diabetic patients, aiding informed device selection.
本研究的目的是系统评价糖尿病患者血糖监测医疗设备的竞争优势。
根据SALSA标准和PRISMA指南进行系统评价。于2023年2月16日至2023年3月1日在俄语和英语数据库中检索符合条件的文章。结果采用叙述、表格和可视化的方式进行综合。检索在以下科学文献数据库中进行：PubMed、IEEE Xplore、谷歌学术、CyberLeninka和eLibrary。
52篇手稿中有22篇符合纳入标准。研究人员确定，所评估设备最具前景和优势的特点包括：无创检查能力；便于精细运动、听力和视力受损患者使用的特性；旨在提高患者依从性的附加装置和软件，包括儿科患者群体；以及在无医源性影响的情况下提高分析速度和准确性的设备属性。
随着糖尿病患病率的增加，血糖控制对于预防并发症至关重要。市场上有众多具有不同特点的血糖监测设备（GMD），这使得选择具有挑战性。我们的研究系统地对每种GMD模型对糖尿病患者的优势进行了分类，有助于做出明智的设备选择。
